Directiva (UE) 2017/1572 de la Comisión, de 15 de septiembre de 2017, por la que se complementa la Directiva 2001/83/CE del Parlamento Europeo y del Consejo en lo que respecta a los principios y directrices de las prácticas correctas de fabricación de los medicamentos de uso humano
› ›
Enlazado como:Extracto
Directiva (UE) 2017/1572 de la Comisión, de 15 de septiembre de 2017, por la que se complementa la Directiva 2001/83/CE del Parlamento Europeo y del Consejo en lo que respecta a los principios y directrices de las prácticas correctas de fabricación de los medicamentos de uso humano
No longer available (Autolink)
Ver el contenido completo de este documento
Documentos citados
- Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
- Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
- Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
- Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use (Text with EEA relevance)
- Consolidated version of the Treaty on the Functioning of the European Union 2016/C 202/01
